NRNP 6566 Week 6 Mid-term Study Guide Week 1 to 5
$20.00
(NRNP 6566 Week 6 Mid-term, NRNP 6566 Week 6 Mid-term)
- Question: Describe the cytochrome P450 system. Describe how inducers and inhibitors affect the cytochrome system and how that affects the half-life of medications.
- Question: Describe the affect on low and high albumin levels on active drug levels especially for drugs that are highly protein bound.
- Question: Describe ways to lessen the hepatic first pass effect
- Question: Be able to calculate creatinine clearance using the Cockgraft Gault equation
- Question: Describe what determines the frequency of drug administration
- Question: Be familiar with the Beers criteria and how to use it
- Question: Describe factors that affect absorption, distribution, metabolism and excretion
- Question: Define narrow therapeutic index How would you monitor a patient with a narrow the rapeutic index?
- Question: Describe how aging affect absorption, distribution, metabolism, andexcretion
- Question: Identify and describe 12 lead EKGs that demonstrate:
- Question: Identify and describe the medications to treat each one of the EKGS listed in#1
- Question: Distinguish between dihydropyridine and non-dihydropyridine calcium channel blocker. Know what conditions each class would be used to treat.
- Question: Describe the medications to treat atrial fibrillation (rate, rhythm, and embolus prevention). Know the side effects, needed monitoring, and interaction for each of these medications for rate control.
- Question: Calculate a CHADS2 score and describe treatment based on the score
- Question: Describe the symptoms of hyperthyroidism, lab values that are altered, and medications to treat the disease and symptoms.
- Question: Identify when cardioversion is … and relevant testing that should occur prior toit.
- Question: Describe ACLS guidelines
- Question: Know the diagnostic criteria for hypertension, hypertensive urgency, and hypertensive Describe goals of treatment (goalBP)
- Question: Identify medications to treat hypertension … on ethnicity and co-existingconditions. Be very familiar with JNC guidelines. Be familiar with dosing and side effects of each medication class (ACE-I, ARB, Beta blockers,diuretics)
- Question: Describe medication, side effects, and drugs for IV treatment ofhypertensive emergencies.
- Question: Describe end organ damage related to hypertension. Identify what diagnostics are … and medications to treat hypertension (all stages … in#1).
- Question: Identify the 4 types of shock and be able to distinguish between all Know the classic presentation (symptoms), medications to treat, and hemodynamic readings that would lead to diagnosis of each.
- Question: Know the Surviving Sepsis guidelines for diagnosis, monitoring, and medications to treat.
- Question: Be able to distinguish the 4 stages of sepsis. Differentiate the stages bysymptoms.
- Question: Interpret a WBC differential. Distinguish between a bacterial and viral infections based on the differential.
- Question: Explain the mechanism of action and common side effects of dobutamine, norepinephrine, labetalol, and amiodarone.
- Question: Distinguish the actions and effects between dopamine and dobutamine.
- Question: Be very familiar with the CHEST guidelines on anticoagulation management
- Question: Identify medications and dosages to treat an acute pulmonary embolism. Include the medications, dosages, and transition from injectable to oral medications
- Question: Describe medications … to prevent PE in surgical, orthopedic, and trauma patients. Know dosages and length of treatment suggested.
- Question: Describe how to manage warfarin (initiation, monitoring, and dose adjustments)
- Question: Identify what patients would not … eligible for oral anti coagulants
- Question: Describe how to bridge a patient taking warfar in that is undergoing Distinguish between HIT, TTP, ITP, and DIC. Describe diagnostics and treatment for all three
- Question: Describe appropriate labs and monitoring guidelines for all anti coagulant medications.
- Question: Identify INR goals for all diagnosis
- Question: Treatment recommendations for patients that had coronary stent placement and ison Plavix (duration of treatment).